Is ADCT or ADXN more undervalued in 2026?

CirclFi compares ADC Therapeutics SA (ADCT) and Addex Therapeutics Ltd (ADXN) using 13 institutional-grade valuation models. ADCT has a Quality of Company score of 6.5/10 while ADXN scores 5.5/10.

Which is a better buy — ADCT or ADXN?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ADCT and ADXN valuations compare?

ADCT at $3.45 and ADXN at $6.82 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ADCT vs ADXN Valuation Comparison 2026 — Intrinsic Value Analysis

ADCT

Biotechnology

ADC Therapeutics SA

Quality

6.5

out of 10

Value Trap

SAFE

Price

$3.45

Last close

Models

9/13

Active

ADXN

Biotechnology

Addex Therapeutics Ltd

Quality

5.5

out of 10

Value Trap

SAFE

Price

$6.82

Last close

Models

6/13

Active

Model-by-Model Comparison

Model	Type	ADCT Fair Value	ADCT Upside	ADXN Fair Value	ADXN Upside
Bayesian DCF	Intrinsic	$1.33	-61.4%	—	—
Earnings Power Value	Intrinsic	$3.34	-12.8%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.59	-82.8%	$13.22	+88.8%
Dynamic NAV	Asset-Based	—	—	$6.04	-11.4%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ADCT vs ADXN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ADCT vs ADXN — Which Stock Is More Undervalued?

ADCT scores higher with a 6.5/10 quality rating vs ADXN's 5.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing ADC Therapeutics SA (ADCT) and Addex Therapeutics Ltd (ADXN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ADCT currently trades at $3.45 with a QOC of 6.5/10, while ADXN trades at $6.82 with a QOC of 5.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).